Nautilus Biotechnology, Inc. - Common stock, par value $0.0001 per share (NAUT)

Q: What does CUSIP 63909J108 represent in this 13F holders report?

CUSIP 63909J108 is the security identifier for NAUT - Nautilus Biotechnology, Inc. - Common stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held NAUT - Nautilus Biotechnology, Inc. - Common stock, par value $0.0001 per share in Q4 2021?

77 institutional investors reported NAUT - Nautilus Biotechnology, Inc. - Common stock, par value $0.0001 per share for Q4 2021. Use the holders table for investor-level position and value details.

CUSIP: 63909J108

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class: Equity / Common stock, par value $0.0001 per share
Shares outstanding: 130,367,883
Total 13F shares: 41,913,282
Share change: +775,608
Total reported value: $217,115,889
Put/Call ratio: 54%
Price per share: $5.18
Number of holders: 77
Value change: +$1,259,255
Number of buys: 41
Number of sells: 23

Quarterly Holders Quick Answers

What is CUSIP 63909J108?
CUSIP 63909J108 identifies NAUT - Nautilus Biotechnology, Inc. - Common stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2022
Previous quarter: Q3 2021

Recent filing periods for CUSIP 63909J108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of NAUT - Nautilus Biotechnology, Inc. - Common stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
PERCEPTIVE ADVISORS LLC	13F	Company	6.8%	8,911,151	$54,714,000	—	30 Sep 2021	13F
AH Equity Partners Bio II, L.L.C.	3/4/5	10%+ Owner	— class O/S missing	17,653,917	$35,833,921	—	09 Jun 2021	3/4/5
Madrona Venture Group, LLC	13F	Company	4.6%	6,020,770	$30,663,000	—	30 Sep 2021	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	1.9%	2,436,430	$14,960,000	—	30 Sep 2021	13F
Comprehensive Financial Management LLC	13F	Company	1.7%	2,224,619	$13,659,000	—	30 Sep 2021	13F
Bain Capital Life Sciences Investors, LLC	13F	Company	1.5%	2,000,000	$12,280,000	—	30 Sep 2021	13F
Ally Bridge Group (NY) LLC	13F	Company	1.2%	1,500,000	$9,210,000	—	30 Sep 2021	13F
FRANKLIN RESOURCES INC	13F	Company	1.2%	1,500,000	$9,210,000	—	30 Sep 2021	13F
AMAZON COM INC	13F	Company	1.1%	1,457,055	$8,946,000	—	30 Sep 2021	13F
ORBIMED ADVISORS LLC	13F	Company	1.1%	1,452,774	$8,920,000	—	30 Sep 2021	13F
BlackRock Finance, Inc.	13F	Company	0.94%	1,228,288	$7,542,000	—	30 Sep 2021	13F
RTW INVESTMENTS, LP	13F	Company	0.84%	1,100,000	$6,588,000	—	30 Sep 2021	13F
Nantahala Capital Management, LLC	13F	Company	0.8%	1,044,267	$6,412,000	—	30 Sep 2021	13F
Affinity Asset Advisors, LLC	13F	Company	0.75%	975,000	$5,987,000	—	30 Sep 2021	13F
FEDERATED HERMES, INC.	13F	Company	0.61%	800,000	$4,912,000	—	30 Sep 2021	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.61%	800,000	$4,912,000	—	30 Sep 2021	13F
Boxer Capital, LLC	13F	Company	0.58%	750,000	$4,605,000	—	30 Sep 2021	13F
Rubric Capital Management LP	13F	Company	0.57%	747,607	$4,590,000	—	30 Sep 2021	13F
Tikvah Management LLC	13F	Company	0.54%	708,540	$4,350,436	—	30 Sep 2021	13F
Avidity Partners Management LP	13F	Company	0.46%	600,000	$3,684,000	—	30 Sep 2021	13F
VANGUARD GROUP INC	13F	Company	0.45%	585,862	$3,597,000	—	30 Sep 2021	13F
Alyeska Investment Group, L.P.	13F	Company	0.38%	495,986	$3,045,000	—	30 Sep 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.3%	385,871	$2,369,000	—	30 Sep 2021	13F
SUVRETTA CAPITAL MANAGEMENT, LLC	13F	Company	0.24%	314,835	$1,933,000	—	30 Sep 2021	13F
Board of Trustees of The Leland Stanford Junior University	13F	Company	0.24%	309,492	$1,900,000	—	30 Sep 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.22%	287,649	$1,766,000	—	30 Sep 2021	13F
Casdin Capital, LLC	13F	Company	0.17%	225,000	$1,382,000	—	30 Sep 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.16%	213,845	$1,313,000	—	30 Sep 2021	13F
HILLMAN CO	13F	Company	0.15%	200,000	$1,228,000	—	30 Sep 2021	13F
MARSHALL WACE, LLP	13F	Company	0.13%	166,326	$1,021,000	—	30 Sep 2021	13F
Clearline Capital LP	13F	Company	0.12%	159,130	$977,000	—	30 Sep 2021	13F
STATE STREET CORP	13F	Company	0.12%	157,700	$968,000	—	30 Sep 2021	13F
S.c.a. Candriam	13F	Individual	0.12%	155,000	$952,000	—	30 Sep 2021	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	0.11%	148,300	$911,000	—	30 Sep 2021	13F
BRIDGER MANAGEMENT, LLC	13F	Company	0.1%	126,000	$774,000	—	30 Sep 2021	13F
NORTHERN TRUST CORP	13F	Company	0.07%	90,584	$556,000	—	30 Sep 2021	13F
OCCUDO QUANTITATIVE STRATEGIES LP	13F	Company	0.07%	85,148	$523,000	—	30 Sep 2021	13F
Cubist Systematic Strategies, LLC	13F	Company	0.06%	74,481	$457,000	—	30 Sep 2021	13F
Lombard Odier Asset Management (USA) Corp	13F	Company	0.04%	50,000	$307,000	—	30 Sep 2021	13F
Belvedere Trading LLC	13F	Company	0.04%	52,539	$292,000	—	30 Sep 2021	13F
Skye Global Management LP	13F	Company	0.03%	45,500	$279,000	—	30 Sep 2021	13F
UBS Group AG	13F	Company	0.03%	37,313	$229,000	—	30 Sep 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.03%	36,815	$226,000	—	30 Sep 2021	13F
MORGAN STANLEY	13F	Company	0.02%	30,756	$189,000	—	30 Sep 2021	13F
Alpine Global Management, LLC	13F	Company	0.02%	26,477	$163,000	—	30 Sep 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.02%	22,256	$137,000	—	30 Sep 2021	13F
Paloma Partners Management Co	13F	Company	0.02%	21,791	$134,000	—	30 Sep 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.02%	21,601	$133,000	—	30 Sep 2021	13F
CAPSTONE INVESTMENT ADVISORS, LLC	13F	Company	0.02%	20,672	$127,000	—	30 Sep 2021	13F
GROUP ONE TRADING LLC	13F	Company	0.02%	20,252	$124,000	—	30 Sep 2021	13F

Institutional Holders of Nautilus Biotechnology, Inc. - Common stock, par value $0.0001 per share (NAUT) as of Q4 2021

As of 31 Dec 2021, Nautilus Biotechnology, Inc. - Common stock, par value $0.0001 per share (NAUT) was held by 77 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 41,913,282 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, Madrona Venture Group, LLC, RA CAPITAL MANAGEMENT, L.P., Comprehensive Financial Management LLC, Bain Capital Life Sciences Investors, LLC, Amazon com Inc, ORBIMED ADVISORS LLC, Botty Investors LLC, FRANKLIN RESOURCES INC, and VANGUARD GROUP INC. This page lists 77 institutional shareholders reporting positions in this security for the Q4 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders

Q4 2021 holders

Holder diff

Investor	Q3 2021 Shares	Q4 2021 Shares	Share Diff	Share Chg %	Q3 2021 Value $	Q4 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.